Putting an end to cervical cancer in Tennessee!

Cervical Cancer-Free Tennessee

Members

Pamela C. Hull, PhD

Vanderbilt University

Kelly L. Moore, MD, MPH

Tennessee Department of Health

Pamela C. Hull, Ph.D., is an Assistant Professor in the Vanderbilt University School of Medicine in the Department of Medicine, Division of Epidemiology.  Prior to joining Vanderbilt faculty, she served as Associate Director of the Center for Prevention Research at Tennessee State University.  She earned a Bachelor’s degree in Sociology from Duke University, and a Masters and Ph.D. in Sociology from Vanderbilt University.  Dr. Hull is a medical sociologist with expertise in the development and testing of behavioral interventions to promote cancer prevention behaviors in youth. Her research focuses on increasing HPV vaccine use, healthy eating, and physical activity among Hispanic and African American youth, using social marketing and new technology applications.  Dr. Hull has over 10 years of experience as an investigator conducting community-based participatory research, including designing and testing behavioral interventions using observational and randomized controlled study designs.

Kelly L. Moore, MD, MPH, is the Director of the Tennessee Immunization Program at the Tennessee Department of Health and an Assistant Clinical Professor of Preventive Medicine at the Vanderbilt School of Medicine. Dr. Moore earned her undergraduate and medical degrees at Vanderbilt, and her Master of Public Health degree from the Harvard School of Public Health. After completing her internship in Pediatrics at the Johns Hopkins Hospital in Baltimore, she served as an Epidemic Intelligence Service Officer and completed her residency in Preventive Medicine with the Centers for Disease Control and Prevention (CDC). Dr. Moore directs or advises on state immunization policy, practice, and legislation and educates immunization providers, the public and the media. She represents the national Association of Immunization Managers on the CDC’s Advisory Committee on Immunization Practices, where she helps shape national immunization guidelines. The mission of the Tennessee Immunization Program is to minimize the burden of vaccine-preventable diseases by optimizing the use of vaccines by Tennesseans of all ages: one of her top priorities is to increase unacceptably low immunization rates among our adolescents, especially rates of HPV vaccination.

StateWide Co-Chairs

The Cervical Cancer Free Tennessee (CCFTN) coalition is led by the Tennessee Department of Health and is composed of practitioners, educators, partners, advocates and researchers committed to eliminating cervical cancer by 2040.  By working through the Tennessee Cancer Coalition, the aim is to involve local, community-based stakeholders to address cervical cancer screening and HPV vaccination for all eligible Tennesseans. Regional committees are developing and implementing community based interventions, with a focus on the counties with the highest cervical cancer incidence rates.  The objectives of these activities are to educate residents, encourage women’s health exams, and increase vaccine uptake in adolescents.  University researchers working in the areas of provider training and social marketing are developing and testing projects to increase Pap tests and vaccine uptake in specific populations.

About CCFTN

Mission Statement

The mission of the Cervical Cancer Free Tennessee coalition (CCFTN) is to decrease the incidence of cervical cancer in Tennessee through vaccination, screening, and early detection. 

To accomplish this mission, CCFTN promotes primary and secondary prevention strategies through education directed at both clinicians and consumers.  For primary prevention, given that the human papillomavirus (HPV) causes nearly all cervical cancers, CCFTN focuses on implementation of HPV vaccine recommendations (boys and girls ages 11-12, with catch up for older adolescents). For secondary prevention, CCFTN focuses on enhanced access to care to include comprehensive screening and prompt intervention for abnormal screening results. By combining these two strategies, our goal is to decrease the incidence of HPV related pathology and subsequent morbidity and mortality in Tennessee.